GROSSO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 726
EU - Europa 416
AS - Asia 109
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.304
Nazione #
US - Stati Uniti d'America 711
GB - Regno Unito 128
CN - Cina 79
IT - Italia 61
DE - Germania 58
SE - Svezia 50
TG - Togo 22
RU - Federazione Russa 20
IN - India 18
CI - Costa d'Avorio 17
BE - Belgio 16
UA - Ucraina 16
CA - Canada 15
IE - Irlanda 15
FR - Francia 12
EE - Estonia 11
CH - Svizzera 10
ZA - Sudafrica 10
BG - Bulgaria 7
RO - Romania 5
FI - Finlandia 4
JO - Giordania 4
SG - Singapore 4
IR - Iran 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
ES - Italia 1
ID - Indonesia 1
NG - Nigeria 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 1.304
Città #
Southend 112
Fairfield 88
Chandler 85
Ann Arbor 75
Ashburn 70
Wilmington 53
Woodbridge 48
Houston 45
Seattle 37
Cambridge 34
Princeton 26
Lomé 22
Abidjan 17
Brussels 16
Dublin 15
Beijing 14
Bologna 14
Ottawa 14
Bremen 11
Nanjing 11
Padova 11
Westminster 11
Berlin 9
Bern 9
San Diego 8
Jacksonville 7
Jinan 7
Redmond 7
Redwood City 7
Sofia 7
Changsha 6
Tianjin 6
Turin 6
Guangzhou 5
Milan 5
Nanchang 5
Saint Petersburg 5
Amman 4
Jiaxing 4
Singapore 4
Boardman 3
Chieti 3
Hebei 3
Helsinki 3
London 3
Ningbo 3
Shenyang 3
Amsterdam 2
Bühl 2
Haikou 2
Lanzhou 2
Montechiarugolo 2
Phoenix 2
Washington 2
Xiangfen 2
Alexandria 1
Bochum 1
Bulle 1
Cagliari 1
Centro 1
Dearborn 1
Des Moines 1
Frankfurt Am Main 1
Grafing 1
Hangzhou 1
Jakarta 1
Kiev 1
Kuban 1
Lagos 1
Lappeenranta 1
Las Vegas 1
Leawood 1
Los Angeles 1
Mahé 1
Montreal 1
Mülheim 1
Olalla 1
Riccione 1
Riyadh 1
San Francisco 1
San Venanzo 1
Shanghai 1
Taiyuan 1
Taizhou 1
Tallinn 1
Verona 1
Zanjan 1
Totale 1.009
Nome #
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 149
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 145
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases 138
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 125
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 124
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 122
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 120
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 116
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 109
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 104
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 93
Totale 1.345
Categoria #
all - tutte 3.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020427 47 13 4 25 51 31 54 61 65 40 16 20
2020/2021163 46 14 10 9 2 7 4 17 21 8 12 13
2021/2022217 13 4 24 9 23 11 7 16 6 15 60 29
2022/2023320 35 56 17 52 19 18 8 18 39 16 27 15
2023/202482 3 15 3 11 8 11 5 14 1 4 3 4
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 1.345